Last reviewed · How we verify
Evaluation of the Usefulness of a Treat and Extend Regimen Using Ranibizumab for Neovascular Age-Related Macular Degeneration.
To evaluate the visual outcome, number of injections and visits, and the effect of mental status of a treat and extend regimen in managing neovascular age-related macular degeneration with intravitreal ranibizumab.
Details
| Lead sponsor | Nagoya City University |
|---|---|
| Phase | Phase 4 |
| Status | COMPLETED |
| Enrolment | 78 |
| Start date | 2014-01 |
| Completion | 2019-03 |
Conditions
- Neovascular Age-related Macular Degeneration
Interventions
- Intraviteal Ranibizumab 0.5mg
Primary outcomes
- Visual acuity — One Year
Countries
Japan